Carcinoid Lung Tumor (cont.)
Medical Author:
George Schiffman, MD, FCCP
George Schiffman, MD, FCCPDr. Schiffman received his B.S. degree with High Honors in biology from Hobart College in 1976. He then moved to Chicago where he studied biochemistry at the University of Illinois, Chicago Circle. He attended Rush Medical College where he received his M.D. degree in 1982 and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his Internal Medicine internship and residency at the University of California, Irvine. Medical Editor:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. IN THIS ARTICLEOutlookThe outlook of carcinoid lung tumors depends on the size of the tumor, the type of tumor (typical or atypical), and whether the tumor has spread to the lymph nodes at the time of diagnosis. Because carcinoid lung tumors grow and spread slowly, they often are discovered at an early stage. The outlook for people with early-stage typical carcinoid lung tumors is usually very good. Atypical carcinoid lung tumor is more likely to have spread to nearby tissues or lymph nodes at the time of diagnosis. Survival rates are lower for people with atypical carcinoid tumors and carcinoid tumors that have spread to other parts of the body. Carcinoid lung tumors generally have a better outlook than other forms of lung cancer. Persons with carcinoid lung tumors have an overall 5-year survival rate of 78%-95% and a 10-year survival rate of 77%-90%. Persons with typical carcinoid tumors have been found to have a much better outlook than those with the atypical variety. Atypical carcinoid tumors have been associated with a 5-year survival rate of 40%-60% and a 10-year survival rate of 31%-60%. Regardless of the type of carcinoid lung tumor, the presence of lymph node metastases at the time of resection has a significant effect on outlook. The presence of carcinoid syndrome in the absence of spread to the lymph node or other tissues does not seem to affect the outlook adversely. Next Page: Must Read Articles Related to Carcinoid Lung Tumor
Bronchoscopy
Bronchoscopy is performed to view the inside of a person's airway and lungs. There are two types of bronchoscopy, 1) rigid bronchoscopy and 2) flexible bronchos...learn more >>
Chest X-Ray
Chest X-ray is a common procedure ordered to diagnose certain diseases and conditions such as pneumonia, congestive heart failure, emphysema, lung masses or nod...learn more >>
Coughs
A cough is a symptom of an underlying disease or condition. A chronic or persistent cough may signal certain lung conditions that should be evaluated by a healt...learn more >>
|
Women's Health
Find out what women really need.
From WebMD
Lung Disease/COPD Resources
Featured Centers
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Carcinoid Lung Tumors »
Carcinoid tumors of the lung are a fascinating but uncommon group of pulmonary neoplasms.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies


